Search results for: 'android ed poc terminals forecast 2025'

Since the onset of the COVID-19 pandemic, molecular diagnostics mergers/acquisition transactions and product launches for infectious disease testing are indicating a pivot toward a new direction or an enhancement of portfolios. The emergence of saliva sample testing and the transition to PCR-based syndromic and direct-to-consumer testing for respir...

This study examines and analyses the European market for medical grade PCs, MCAs, and bedside terminals. The research service presents the market definition and its dynamics. It examines the market in terms of various factors that influence the market and also discusses the competitive trends along with the geographical trends prevailing in the mar...

Today, the healthcare industry is focused toward patient centric care and preventative healthcare. Preventative healthcare involves regular screening and diagnosis for diseases before the condition becomes fatal. Early diagnosis improves the clinical outcome of the patients, reduces emergency visits, and subsequently healthcare costs. Usually, ear...

There is a growing demand for mobile imaging equipment in low and middle-income countries due to the limited financial resources to procure, operate, and maintain expensive medical imaging equipment. Other challenges include irregular power supply, poor network connectivity, inadequate site infrastructure, and delays because of the geographical dis...

Smartphone-based point-of-care (POC) diagnostics are rapidly emerging as medical diagnostics, enabling remote or self-monitoring tools for general wellness and a range of health conditions. Smartphones enable low-cost, rapid, and handy POC diagnostics. Intrinsic sensors of smartphones or extrinsic sensing devices working with intelligent data analy...

This research analyzes how point-of-care (PoC) diagnostics is evolving from simple tests to decentralized, connected, and clinically actionable testing platforms across hospitals, outpatient settings, homes, and pharmacies.The study assesses key technology shifts, including rapid molecular testing, lateral flow assays, microfluidics, biosensors, sm...

02 Sep 2025  |  Global  |  Technology Research

Technological Advances in Engineered Cell Therapies, Global, 2025–2029

Emerging Trends and Technologies in Engineered Cell Therapies

Infographics

×

Engineered cell therapies have become a revolutionary medical field, surpassing conventional methods such as systemic medications and prominent immunosuppression to provide long-lasting, programmable, and targeted treatments for complicated diseases. Recent technical developments in engineered cell therapies examine how the rapid growth of cell eng...

Cardiac troponin (cTn) biomarkers are the gold standard in myocardial infarction (MI) diagnosis, leading healthcare professionals to use cTn diagnostics. In addition, a rising number of patients visit emergency departments (EDs) with cardiac complaints, increasing ED demand for kits that can rapidly rule MI in or out. Both factors serve as signif...

This study provides an overview of the global point-of-care testing (POCT) industry, which refers to any routine or specialized lab pathology testing conducted rapidly, on-site/near the site of the patient, where care or treatment is provided. COVID-19 radicalization is changing the global diagnostics landscape. Consolidation trends, structural s...